Related Experiment Video
Updated: Jun 12, 2025

Determination of the Relative Potency of an Anti-TNF Monoclonal Antibody mAb by Neutralizing TNF Using an In Vitro Bioanalytical Method
Published on: September 16, 2017
Non-constant mean relative potency for antibody-dependent cellular cytotoxicity assays
Paul Faya1, Tianhui Zhang1, Wendy Walton2
1Global Statistical Sciences, Eli Lilly and Company, Indianapolis, IN, USA.
A new method addresses challenges in bioassay potency determination when concentration-response curves differ. This non-constant mean relative potency approach provides a reliable summary statistic for quality control in biological product analysis.
Area of Science:
- Biopharmaceutical analysis
- Quantitative pharmacology
- Analytical chemistry
Background:
- Bioassays are critical for ensuring biological product potency and stability.
- Traditional relative potency calculations assume similar concentration-response curve shapes, which is not always biologically feasible.
- Non-similar curve shapes limit the applicability of standard bioassay methods, particularly in antibody-mediated cytotoxicity assays, toxicology, and pharmacology.
Purpose of the Study:
- To introduce a novel non-constant mean relative potency approach for bioassays.
- To provide a method for calculating a summary statistic that reflects changing relative potency.
- To enable reliable batch calibration and quality control when curve similarity is not met.
Main Methods:
- Development of a non-constant mean relative potency method averaging potency across a common concentration range.
- Establishment of inferential statistical methods for the proposed summary statistic.
- Simulation studies to evaluate the performance of the new method under various non-constant relative potency scenarios and assay conditions.
Main Results:
- The proposed non-constant mean relative potency approach effectively captures changing potency characteristics.
- The method provides a robust summary statistic suitable for quality control applications.
- Simulation results demonstrate the method's utility across diverse non-constant relative potency situations.
Conclusions:
- The non-constant mean relative potency approach offers a viable solution for bioassays where traditional assumptions fail.
- This method enhances the accuracy and reliability of potency determination for biological products.
- The developed inferential methods and simulations support the practical application of this approach in biopharmaceutical quality control.
More Related Videos
07:25In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
Published on: May 4, 2017
05:21Author Spotlight: Optimizing Antibody-Based Cancer Treatments via Antibody-Dependent, Cell-Mediated Cytotoxicity Assay
Published on: September 13, 2024